Real-life treatment and outcome data for patients with advanced NSCLC receiving treatments containing bevacizumab – data from the clinical registry on lung cancer (TLK).
Studie: TLK; Indikation: Bronchialkarzinom; Jahr: 2014; Veranstaltung: DGHO; Journal: Oncology Research and Treatment